Date: February 21, 2022
“Moderna’s stock price rose precipitously as the company’s investors benefited from rollout of the company’s COVID vaccine. But now that the future of vaccines is uncertain, Moderna’s stock has been steadily declining, losing $140 billion in value in just a few months.
Jimmy and The Dive host Jackson Hinkle discuss the vaccine manufacturer’s declining fortunes.”
===